← FDA DRUG APPROVALS

FDA ANDA · ANDA079078

GRANISETRON HYDROCHLORIDE

Sponsor: RISING

APPLICATION
ANDA079078
TYPE
ANDA
ORIGINAL APPROVAL
2009-09-14
LATEST ACTION
2015-09-01
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

GRANISETRON HYDROCHLORIDEPrescription
GRANISETRON HYDROCHLORIDE EQ 1MG BASE/ML (EQ 1MG BASE/ML) · INJECTABLE · INJECTION
GRANISETRON HYDROCHLORIDEPrescription
GRANISETRON HYDROCHLORIDE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) · INJECTABLE · INJECTION

Approval history

2015-09-01Labeling · Supplement 3 · standardAP
2014-09-18Labeling · Supplement 2 · standardAP
2011-03-31Labeling · Supplement 1AP
2009-09-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →